Physician
Neurology
Dr. Ranjan Duara, MD
|
|
Give Review
Ranjan Duara works in the field of Neurology. He studied medicine at Christian Medical College Vellore. He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Ranjan Duara is also a published MD. He has 100 publication published. The most recent publication is: The APOE-epsilon4 allele and Alzheimer disease among African Americans, Hispanics, and whites. Dr. Ranjan Duara is registered with Medicare.
Publications
- Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density.
- Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's Disease spectrum.
- Rarity of the Alzheimer Disease-Protective APP A673T Variant in the United States.
- Effects of Multiple Genetic Loci on Age at Onset in Late-Onset Alzheimer Disease: A Genome-Wide Association Study.
- Differential clinicopathologic and genetic features of late-onset amnestic Dementias.
- Visual rating and volumetric measurement of medial temporal atrophy in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort: baseline diagnosis and the predic...
- Verbal Fluency Patterns in Mild Cognitive Impairment and Alzheimer's Disease.
- Who wants a free Brain scan? Assessing and correcting for recruitment biases in a population-based sMRI pilot study.
- Amyloid positron emission tomography with (18)F-flutemetamol and structural magnetic resonance imaging in the classification of mild cognitive impairment and Alzheimer...
- Pathology and temporal onset of visual hallucinations, misperceptions and family misidentification distinguishes dementia with Lewy bodies from Alzheimer's Disease.
- Neuropathologically defined subtypes of Alzheimer's Disease differ significantly from neurofibrillary tangle-predominant dementia.
- Significance of normalization on anatomical MRI measures in predicting Alzheimer's Disease.
- The utility of age-specific cut-offs for visual rating of medial temporal atrophy in classifying Alzheimer's Disease, MCI and cognitively normal elderly subjects.
- Cerebral glucose utilization, as measured with positron emission tomography in 21 resting healthy men between the ages of 21 and 83 years.
- Effects of fasting on ketone body concentrations in healthy men of different ages.
- Brain metabolism in autism. Resting cerebral glucose utilization rates as measured with positron emission tomography.
- Down's syndrome in adults: Brain metabolism.
- Intercorrelations of glucose metabolic rates between Brain regions: application to healthy males in a state of reduced sensory input.
- Dyslexia subtypes: genetics, behavior, and Brain imaging.
- Relations among age, visual memory, and resting Cerebral metabolism in 40 healthy men.
- Brain morphometry in autistic men as measured by volumetric computed tomography.
- Decline in Cerebral glucose utilisation and cognitive function with aging in Down''s syndrome.
- Relation of measured Brain glucose utilisation and cerebral atrophy in man.
- Positron emission tomography in Alzheimer's Disease.
- Positron emission tomography in normal aging and Alzheimer's Disease.
- NIH Conference. Brain imaging: aging and dementia.
- Spastic paraplegia with iron deposits in the basal ganglia: a new X-linked mental retardation Syndrome.
- Brain metabolism as measured with positron emission tomography: serial assessment in a patient with familial Alzheimer's Disease.
- [Cerebral white matter bundle measurements by magnetic resonance imaging].
- Human Brain glucose utilization and cognitive function in relation to age.
- Temporal lobe surface area measurements on MRI in normal and dyslexic readers.
- Age differences in intercorrelations between regional Cerebral metabolic rates for glucose.
- Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's Disease.
- Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer''s Disease.
- [Cerebral white matter bundle alterations in patients with dementia of Alzheimer type and patients with multi-infarct dementia--magnetic resonance imaging study].
- [Size of the corpus callosum in normal subjects and patients with Alzheimer''s Disease--magnetic resonance imaging study].
- Two behavioral states studied in a single PET/FDG procedure: theory, method, and preliminary results.
- Metabolic asymmetries in asymptomatic HIV-1 seropositive subjects: relationship to Disease onset and MRI findings.
- Human task-specific somatosensory activation.
- Apperceptive visual agnosia: a case study.
- Cerebrocerebellar relationship during behavioral activation: a PET study.
- Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer Disease.
- Behavioral activation and the variability of Cerebral glucose metabolic measurements.
- Two behavioral states studied in a single PET/FDG procedure: error analysis.
- Analysis of the c-FOS gene on chromosome 14 and the promoter of the amyloid precursor protein gene in familial Alzheimer's Disease.
- Mutations in the open reading frame of the beta-site APP cleaving enzyme (BACE) locus are not a common cause of Alzheimer''s Disease.
- Genetic evidence for a novel familial Alzheimer's Disease locus on chromosome 14.
- Sensitivity and specificity of three clinical criteria for Dementia with Lewy bodies in an autopsy-verified sample.
- Clinical history, brain metabolism, and neuropsychological function in Alzheimer's Disease.
- Evidence for an Alzheimer Disease susceptibility locus on chromosome 12 and for further locus heterogeneity.
- Head injury and the risk of AD in the MIRAGE study.
- Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type Dementia.
- Frontal hypermetabolism and thalamic hypometabolism in a patient with abnormal orienting and retrosplenial amnesia.
- A new scale for the assessment of functional status in Alzheimer's Disease and related disorders.
- A comparative analysis of functional status among Spanish- and English-speaking patients with Dementia.
- Neuropsychological test performance and prediction of functional capacities among Spanish-speaking and English-speaking patients with Dementia.
- Factors related to medication adherence in memory disorder clinic patients.
- Asymmetric somatosensory activation with right- vs left-hand stimulation: a positron emission tomographic study.
- Risk of dementia among relatives of Alzheimer's Disease patients in the MIRAGE study: What is in store for the oldest old?
- A comparison of familial and sporadic Alzheimer's Disease.
- Association of a functional mu-opioid receptor allele (+118A) with alcohol dependency.
- Diffuse Lewy body Disease: clinical, pathological, and neuropsychological review.
- South Florida Program on Aging and Health. Assessing the prevalence of Alzheimer's Disease in three ethnic groups.
- Predictors of anxiety in patients with Alzheimer's Disease.
- Predominant left hemisphere metabolic dysfunction in Dementia.
- MR signal abnormalities in memory disorder and Dementia.
- Sensitivity and specificity of positron emission tomography and magnetic resonance imaging studies in Alzheimer''s Disease and multi-infarct dementia.
- Association of white matter hyperintensity measurements on Brain MR imaging with cognitive status, medial temporal atrophy, and cardiovascular risk factors.
- A cross-ethnic analysis of risk factors for AD in white Hispanics and white non-Hispanics.
- The APOE-epsilon4 allele and Alzheimer Disease among African Americans, Hispanics, and whites.
- Sensitivity of cerebral glucose metabolism to age, gender, Brain volume, Brain atrophy, and cerebrovascular risk factors.
- Mild cognitive impairment: directions for future research.
- Alzheimer's Disease: interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity, and age of onset.
- Deterioration of functional capacities in Alzheimer's Disease after a 1-year period.
- Alzheimers Disease is not associated with the hypertension genetic risk factors PLA(2) or G protein beta3, either independently or interactively with apolipoprotein E.
- No association between the intronic presenilin-1 polymorphism and Alzheimer's Disease in clinic and population-based samples.
- Positron emission tomographic studies during serial word-reading by normal and dyslexic adults.
- Predictors of positive and negative appraisal among Cuban American caregivers of Alzheimer''s Disease patients.
- Absence of association between Alzheimer Disease and the -491 regulatory region polymorphism of APOE.
- Neural-network classification of normal and Alzheimer's Disease subjects using high-resolution and low-resolution PET cameras.
- No association between the NOS3 codon 298 polymorphism and Alzheimer's Disease in a sample from the United States.
- Association between premorbid history of depression and current depression in Alzheimer''s Disease.
- Frontotemporal dementia and Alzheimer''s Disease: differential diagnosis.
- The occurrence of different intrusive errors in patients with Alzheimer's Disease, multiple cerebral infarctions, and major depression.
- Apolipoprotein-E (APO-E) genotype and symptoms of psychosis in Alzheimer's Disease.
- Family history of dementia is a risk factor for Lewy body Disease.
- Relationship of behavioral and psychological symptoms to cognitive impairment and functional status in Alzheimer''s Disease.
- Clinical characteristics of community-dwelling black Alzheimer's Disease patients.
- A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's Disease.
- Association between Alzheimer's Disease and a functional polymorphism in the Myeloperoxidase gene.
- Depressive symptoms in Alzheimer's Disease. An examination among community-dwelling Cuban American patients.
- Prevalence and correlates of Capgras syndrome in Alzheimer''s Disease.
- Factors associated with depressive symptoms in non-demented community-dwelling elderly.
- Evaluation of a neural-network classifier for PET scans of normal and Alzheimer's Disease subjects.
- Viability of neocortical function shown in behavioral activation state PET studies in Alzheimer Disease.
- Evidence for major gene inheritance of Alzheimer Disease in families of patients with and without apolipoprotein E epsilon 4.
- A comparative analysis of neuropsychological test performance of Spanish-speaking and English-speaking patients with Alzheimer's Disease.
- Evidence that the APOE locus influences rate of Disease progression in late onset familial Alzheimer's Disease but is not causative.
- Interfamilial and intrafamilial phenotypic heterogeneity in familial Alzheimer's Disease.
Schools
Dr MGR Medical University Christian Medical College
Christian Med College Madras University
Cmch
Old Church Hospital
St Louis University Hospital
NiaNih
Procedures Preformed
- EEG (Electroencephalogram)
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Cerebral Artery Thrombosis
- View All
Doctors Specialties
- Neurology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- AvMed
- Blue Care HMO
- BlueDental Choice
- NetworkBlue
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- Employer Group Open Access HMO
- Employer Group PPO
- Emblem Health
- Choice Care PPO
- Preferred PPO
- Select HMO
- Medica
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- POMCO Group
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Neighborhood Health Partnership
- Options PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
Thomas Jefferson University -
Christian Medical College Vellore
Drug Facts
| NPI NUMBER | 1134159700 | |
| NPPES Provider LastName | DUARA | |
| NPPES Provider FirstName | RANJAN | |
| NPPES Provider ZIPCode | 33140 | |
| NPPES Provider State | FL | |
| Specialty Description | Neurology | |
| Total Claim Count | 8410.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1134159700 |
| Last Name Of The Provider | DUARA |
| First Name Of The Provider | RANJAN |
| View All |
Similar Doctors
|
|
Dr. Daniel Feinberg, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Norman J. Schatz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael R. Fetell, MD |
|
|
Dr. Sean M. Shea, MD
This Doctor is OpenDoctor Recommended.
|